CLARIOstar Plus: Official Product Launch at SLAS 2019
Visit booth No. 811 to discover the most flexible plate reader for assay development and more
Visit booth No. 811 to discover the most flexible plate reader for assay development and more
$2.5 million grant from the National Cancer Institute to advance critical work that started in 2018
Made of thin wall polypropylene and designed for precise fit in heat blocks to optimize heat transfer Nonsterile and certified DNase- and RNase-free Autoclavable at 121°C and will withstand centrifugation to 10,000 x g
Individually wrapped and sterile.
The Esco Airstream ® Class II Biological Safety Cabinet is an effective solution in providing operator, product and environmental protection within laboratories and industrial facilities. With the presence of its DC ECM blower, this is the most energy-efficient Class II Biosafety Cabinet in the world with 70% energy savings compared to AC motor. It also features stable and self-compensating airflow, despite building voltage f…
BioClassic Class II Type A2 Series Laminar Flow Biological Safety Cabinets
Accurately quantify trace analytes in a clinical diagnostic lab with the MassTrak ACQUITY UPLC I-Class PLUS/Xevo TQ-XS IVD System.
Designed to be one of the world’s safest, most comfortable and most certified Biosafety Cabinets.
Abbott is collaborating with sports performance technology company Supersapiens to advance this first-of-its-kind product
Showcased at AACR 2026 with data from leading research institutions, including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ)
Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology
Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy
Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months